Eliminating Atherogenesis in Mice by Switching Off Hepatic Lipoprotein Secretion
- 11 March 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (9), 1315-1321
- https://doi.org/10.1161/01.cir.0000054781.50889.0c
Abstract
Background— LDL receptor–deficient “apolipoprotein (apo)-B100–only” mice (Ldlr−/−Apob100/100 have elevated LDL cholesterol levels on a chow diet and develop severe aortic atherosclerosis. We hypoth...Keywords
This publication has 22 references indexed in Scilit:
- Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein EAtherosclerosis, 2002
- Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100Journal of Clinical Investigation, 2000
- Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.Journal of Clinical Investigation, 1998
- Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.Journal of Clinical Investigation, 1997
- Transgenic Mice That Overexpress Mouse Apolipoprotein B: EVIDENCE THAT THE DNA SEQUENCES CONTROLLING INTESTINAL EXPRESSION OF THE APOLIPOPROTEIN B GENE ARE DISTANT FROM THE STRUCTURAL GENEPublished by Elsevier ,1996
- A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine.Journal of Clinical Investigation, 1995
- Inducible Gene Targeting in MiceScience, 1995
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsCell, 1992
- Plasma lipoprotein changes in humans induced by β-interferonAtherosclerosis, 1987